Blood Advances (Aug 2019)
Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML
- Tracy Murphy,
- Jinfeng Zou,
- Georgina S. Daher-Reyes,
- Andrea Arruda,
- Vikas Gupta,
- Caroline J. McNamara,
- Mark D. Minden,
- Aaron D. Schimmer,
- Hassan Sibai,
- Karen W.L. Yee,
- Mariam Korulla,
- Tracy Stockley,
- Suzanne Kamel-Reid,
- Dawn Maze,
- Anne Tierens,
- Scott V. Bratman,
- Andre C. Schuh,
- Steven M. Chan
Affiliations
- Tracy Murphy
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Jinfeng Zou
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Georgina S. Daher-Reyes
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Andrea Arruda
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Vikas Gupta
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Caroline J. McNamara
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Mark D. Minden
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Aaron D. Schimmer
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Hassan Sibai
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Karen W.L. Yee
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Mariam Korulla
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
- Tracy Stockley
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
- Suzanne Kamel-Reid
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
- Dawn Maze
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Anne Tierens
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
- Scott V. Bratman
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Andre C. Schuh
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- Steven M. Chan
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Steven M. Chan, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 101 College St, Room 8-354, Toronto, ON M5G 1L7, Canada
- Journal volume & issue
-
Vol. 3,
no. 15
pp. 2307 – 2311